| Literature DB >> 27748371 |
C Du1, Y Xu1, K Yang1,2, S Chen1, X Wang1, S Wang1, C Wang1, M Shen1, F Chen1, M Chen1, D Zeng1,3, F Li1, T Wang1, F Wang1, J Zhao2, G Ai1, T Cheng1, Y Su1, J Wang1.
Abstract
Estrogen is reported to be involved in thrombopoiesis and the disruption of its signaling may cause myeloproliferative disease, yet the underlying mechanisms remain largely unknown. GATA-binding factor 1 (GATA1) is a key regulator of megakaryocyte (MK) differentiation and its deficiency will lead to megakaryoblastic leukemia. Here we show that estrogen can dose-dependently promote MK polyploidization and maturation via activation of estrogen receptor beta (ERβ), accompanied by a significant upregulation of GATA1. Chromatin immunoprecipitation and a dual luciferase assay demonstrate that ERβ can directly bind the promoter region of GATA1 and activate its transcription. Steroid receptor coactivator 3 (SRC3) is involved in ERβ-mediated GATA1 transcription. The deficiency of ERβ or SRC3, similar to the inhibition of GATA1, leads to the impediment of estrogen-induced MK polyploidization and platelet production. Further investigations reveal that signal transducer and activator of transcription 1 signaling pathway downstream of GATA1 has a crucial role in estrogen-induced MK polyploidization, and ERβ-mediated GATA1 upregulation subsequently enhances nuclear factor erythroid-derived 2 expression, thereby promoting proplatelet formation and platelet release. Our study provides a deep insight into the molecular mechanisms of estrogen signaling in regulating thrombopoiesis and the pathogenesis of ER deficiency-related leukemia.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27748371 DOI: 10.1038/leu.2016.285
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528